Robyn Hunter - 28 Jan 2022 Form 3 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
Director
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Issuer symbol
TENX
Transactions as of
28 Jan 2022
Net transactions value
$0
Form type
3
Filing time
31 Jan 2022, 16:01:46 UTC
Previous filing
29 Apr 2022
Next filing
10 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TENX Common Stock 0 28 Jan 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.